Skip to content

Clinical trials

Observational Hepatitis B trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Observational Country / region: China Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20081
20092
20101
20113
20121
20132
20141
20152
20164
20172
20183
20196
20205
20214
20222
20233
20243
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status20
Completed17
Recruiting12
Active, not recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
First Affiliated Hospital Xi'an Jiaotong University5
Beijing Ditan Hospital4
Beijing Friendship Hospital4
Nanfang Hospital, Southern Medical University4
Third Affiliated Hospital, Sun Yat-Sen University4
Children's Hospital of Chongqing Medical University2
Peking University First Hospital2
Qiu Li2
Affiliated Cancer Hospital & Institute of Guangzhou Medical University1
Beijing Municipal Science & Technology Commission1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B53
Hepatitis B, Chronic14
Carcinoma, Hepatocellular6
Liver Cirrhosis5
Acute-On-Chronic Liver Failure4
Fibrosis3
Virus Diseases3
Bronchiolitis Obliterans Syndrome2
Hepatitis2
Hepatitis C2

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.